Providing market intelligence for more than 35 years

In The News

Amazon Fire TV is selling better than Apple TV

Will the rumored new model help Apple TV get back up the rankings?

If recently released data from Parks Associates is correct, Apple TV slipped down from third to fourth place in the rankings of the most popular streaming media device based on U.S. sales for 2014.

The reason for Apple TV’s fall? Amazon’s Fire TV and Fire Stick, introduced last year. According to the data, Roku is currently in the top spot with 34% of the market, followed by Google’s Chromecast with 23%. As 9to5Mac points out, however, the rumors of an upcoming new version of Apple TV likely had an impact on sales with some consumers opting to wait for the new model. According to rumors, Apple will unveil a new model at its press event on September 9, alongside a new iPhone, a new iPad, and more.

From the article "Amazon Fire TV is selling better than Apple TV" by Kia Kokalitcheva.

Previously In The News

Parks: US Churn Rate For OTT Services Is 19%

This is according to Parks Associates’ latest ‘OTT Video Market Tracker’ stats, which said that overall churn rate for OTT services has been roughly stable for the past year. At the end of 2015, 20...

One in five US subscribers now ‘dissatisfied’ with pay TV service

Some 20% of US pay TV subscribers are now dissatisfied with their pay TV service, according to research from Parks Associates. The future represents a 100% increase since 2013, according to Parks....

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...